REFEYN INC: public contracts won without a rival in United States: 3 uncontested awards; 100% of its awards; 2 without a competition; 1 single bid.
Assay record ASY-US-0ATSNNB07S · Cite as: Assay Systems, “REFEYN INC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/refeyn-inc/
REFEYN INC won 3 of its 3 public contract awards in United States without a rival from 2024-02-14 to 2026-09-18, worth $45.8K: 2 without a competition and 1 after a competition that drew a single bid. 2 buyers awarded it without a rival, the largest National Institutes of Health with 2.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
National Institutes of Health gave REFEYN INC 2 awards: 1 without a competition, 1 after a competition with a single bid. First 2024-02-14, latest 2025-06-26.
National Institute of Standards and Technology gave REFEYN INC 1 award: 1 without a competition, 0 after a competition with a single bid. First 2026-09-18, latest 2026-09-18.
| Date | Buyer | How | Value | Stated reason |
|---|---|---|---|---|
| 2026-09-18 | National Institute of Standards and Technology 1333ND26PNB640433 | No competition NOT COMPETED UNDER SAP | $9.4K | LESS THAN OR EQUAL TO THE MICRO-PURCHASE THRESHOLD |
| 2025-06-26 | National Institutes of Health 75N93020P00591 | Single bid COMPETED UNDER SAP | $-2,200 | — |
| 2024-02-14 | National Institutes of Health 75N92024P00095 | No competition NOT COMPETED | $38.6K | ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER) |
Every uncontested award in United States · All countries · REFEYN INC in the register
Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.